Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. (Q36096614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

main subject

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Maciej Krasnodębski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Irena Kosińska

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Michał Wasilewicz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

M Grąt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ł Masior

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Z Lewandowski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

K Grąt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J Stypułkowski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

S Rejowski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M Gałęcka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

P Szachta

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M Krawczyk

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

1 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1687-1691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

Role of Gut Microbiota in Liver Disease

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Gut microbiota and liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Microbiota-liver axis in hepatic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Alterations of the human gut microbiome in liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

The relevance of intestinal dysbiosis in liver transplant candidates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Long-term results of liver resection in the treatment of patients with hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Predictors of Early Hospitalization After Deceased Donor Liver Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Inflammation and liver tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Multiple interactive factors in hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Colonization of the human gut by E. coli and colorectal cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2016.01.077

10.1016/J.TRANSPROCEED.2016.01.077

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27496472%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference